Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)

• Status: Completed
• Trial end date: 2010-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a multicenter study to evaluate the efficacy and safety of MK0476 versus placebo in participants with chronic asthma who actively smoke cigarettes.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Fluticasone; Montelukast

Criteria

Inclusion Criteria:

• Participants with chronic asthma who actively smoke at least 0.5 to no more than 2 packs of cigarettes a day

Exclusion Criteria:

• Participant cannot have a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or emphysema.